BioCentury
ARTICLE | Strategy

Kosan Chronicles

June 2, 2008 7:00 AM UTC

Prior to last week's proposed acqusition by Bristol-Myers Squibb, Kosan had been trading at an all-time low of about $1.50 per share. Selected events tracked against Kosan's weekly stock price since the company sold its IPO in October 2000.

A. 10/9/00 - Kosan(NASDAQ:KOSN) raises $70M in an IPO...